Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Mayo Clinic Neuro-Informatics Laboratory, Mayo Clinic, Rochester, MN, USA.
Neurocrit Care. 2024 Aug;41(1):228-243. doi: 10.1007/s12028-023-01937-5. Epub 2024 Feb 14.
Acute bacterial meningitis (ABM) is associated with severe morbidity and mortality. The most prevalent pathogens in community-acquired ABM are Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Other pathogens may affect specific patient groups, such as newborns, older patients, or immunocompromised patients. It is well established that ABM is associated with elevated intracranial pressure (ICP). However, the role of ICP monitoring and management in the treatment of ABM has been poorly described.An electronic search was performed in four electronic databases: PubMed, Web of Science, Embase, and the Cochrane Library. The search strategy chosen for this review used the following terms: Intracranial Pressure AND (management OR monitoring) AND bacterial meningitis. The search yielded a total of 403 studies, of which 18 were selected for inclusion. Eighteen studies were finally included in this review. Only one study was a randomized controlled trial. All studies employed invasive ICP monitoring techniques, whereas some also relied on assessment of ICP-based on clinical and/or radiological observations. The most commonly used invasive tools were external ventricular drains, which were used both to monitor and treat elevated ICP. Results from the included studies revealed a clear association between elevated ICP and mortality, and possibly improved outcomes when invasive ICP monitoring and management were used. Finally, the review highlights the absence of clear standardized protocols for the monitoring and management of ICP in patients with ABM. This review provides an insight into the role of invasive ICP monitoring and ICP-based management in the treatment of ABM. Despite weak evidence certainty, the present literature points toward enhanced patient outcomes in ABM with the use of treatment strategies aiming to normalize ICP using continuous invasive monitoring and cerebrospinal fluid diversion techniques. Continued research is needed to define when and how to employ these strategies to best improve outcomes in ABM.
急性细菌性脑膜炎(ABM)与严重的发病率和死亡率相关。社区获得性 ABM 中最常见的病原体是肺炎链球菌、脑膜炎奈瑟菌和流感嗜血杆菌。其他病原体可能影响特定的患者群体,如新生儿、老年患者或免疫功能低下的患者。已有充分证据表明,ABM 与颅内压升高(ICP)相关。然而,ICP 监测和管理在 ABM 治疗中的作用尚未得到充分描述。
PubMed、Web of Science、Embase 和 Cochrane Library。为本次综述选择的搜索策略使用了以下术语:颅内压和(管理或监测)和细菌性脑膜炎。搜索共产生了 403 项研究,其中 18 项被选入。最终纳入了 18 项研究。只有一项研究是随机对照试验。所有研究均采用了侵入性 ICP 监测技术,而有些研究还依赖于基于临床和/或影像学观察的 ICP 评估。最常用的侵入性工具是外部脑室引流管,既可用于监测也可用于治疗升高的 ICP。纳入研究的结果表明,ICP 升高与死亡率之间存在明确关联,当使用侵入性 ICP 监测和管理时,可能会改善结局。最后,该综述强调了缺乏明确的标准化协议来监测和管理 ABM 患者的 ICP。
本综述提供了对侵入性 ICP 监测和基于 ICP 的管理在 ABM 治疗中的作用的深入了解。尽管证据确定性较弱,但目前的文献表明,使用旨在通过连续侵入性监测和脑脊液引流技术使 ICP 正常化的治疗策略,可改善 ABM 患者的预后。需要进一步研究来确定何时以及如何使用这些策略,以最大程度地改善 ABM 的预后。